Table 2.
Characteristics of familial adenomatous polyposis patients with and without gastric adenomas (n = 97)
| Variables | Gastric adenoma present (n = 9) | No gastric adenoma (n = 88) | p value |
|---|---|---|---|
|
Age: range +/- SD; yr |
36 +/- 12 |
48 +/- 15 |
0.02 |
|
Male (%) |
4 (44%) |
37 (42%) |
1.00 |
|
Race |
|
|
0.05 |
| White |
6 (67%) |
81 (92%) |
|
| Non-white |
3 (33%) |
7 (8%) |
|
|
Family history of gastric cancer |
0 (0%) |
3 (3%) |
0.85 |
|
Fundic gland polyps |
7 (78%) |
68 (77%) |
1.00 |
|
Chronic gastritis |
2 (22%) |
0 (0%) |
0.01 |
|
Any duodenal adenoma |
7 (78%) |
67 (76%) |
1.00 |
|
Modified Spigelman’s grade III or IV duodenal polyposis |
4 (44%) |
24 (27%) |
0.27 |
|
Desmoid tumor |
5 (56%) |
19 (22%) |
0.04 |
|
NSAID or COX2 inhibitor use |
4 (44%) |
32 (36%) |
0.85 |
| Proton pump inhibitor use | 4 (44%) | 25 (28%) | 0.58 |